Sign up
Pharma Capital
Market: AIM:HCM
52-week High/Low: 5,920.00p / 2,840.00p
Sector: Health Care, Equipment & Services
Market Cap: 3,219.36M

Chi-Med is a China-based healthcare group that researches, develops, manufactures & sells pharmaceuticals and health-related consumer products.

Hutchison China MediTech is traded in the ISDX Exchange HERE

Hutchison China MediTech Limited

Interactive graph

col 3
col 4
col 5
col 6
View full HCM profile View Profile
View All

Market Reports Including HCM


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.